lobbying_activities: 2772337

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2772337	7337541c-fe74-4dbb-94e7-bdc7a5b088c8	Q1	THE NICKLES GROUP, LLC	293335	OMEROS CORPORATION	2022	first_quarter	MMM	Monitored H.R. 5376, Build Back Better Act, as it relates to prescription drug prices; S. 586 / H.R.3259, Non-Opioids Prevent Addiction In the Nation Act (NOPAIN Act) and issues involving access for patients to non-opioid alternatives.	HOUSE OF REPRESENTATIVES,SENATE	80000		0	0	2022-04-12T15:55:47-04:00